244 related articles for article (PubMed ID: 27334213)
1. Percutaneous Sentinel Node Biopsy in Breast Cancer: Results of a Phase 1 Study.
Pairawan SS; Cora C; Olaya W; Deisch J; Garberoglio R; Solomon N; Senthil M; Garberoglio C; Lum SS
Ann Surg Oncol; 2016 Oct; 23(10):3330-6. PubMed ID: 27334213
[TBL] [Abstract][Full Text] [Related]
2. Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.
Tsugawa K; Noguchi M; Miwa K; Bando E; Yokoyama K; Nakajima K; Michigishi T; Tonami N; Minato H; Nonomura A
Breast Cancer; 2000 Jan; 7(1):87-94. PubMed ID: 11029778
[TBL] [Abstract][Full Text] [Related]
3. Intradermal isotope injection: a highly accurate method of lymphatic mapping in breast carcinoma.
Boolbol SK; Fey JV; Borgen PI; Heerdt AS; Montgomery LL; Paglia M; Petrek JA; Cody HS; Van Zee KJ
Ann Surg Oncol; 2001; 8(1):20-4. PubMed ID: 11206219
[TBL] [Abstract][Full Text] [Related]
4. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid.
Kern KA
J Am Coll Surg; 2002 Oct; 195(4):467-75. PubMed ID: 12375751
[TBL] [Abstract][Full Text] [Related]
5. Contrast-Enhanced Ultrasound Biopsy of Sentinel Lymph Nodes in Patients with Breast Cancer: Implications for Axillary Metastases and Conservation.
Cox K; Weeks J; Mills P; Chalmers R; Devalia H; Fish D; Sever A
Ann Surg Oncol; 2016 Jan; 23(1):58-64. PubMed ID: 25990967
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node biopsy in patients with operable breast cancer treated with neoadjuvant chemotherapy.
Rebollo-Aguirre AC; Gallego-Peinado M; Menjón-Beltrán S; García-García J; Pastor-Pons E; Chamorro-Santos CE; Ramos-Font C; Salamanca-Ballesteros A; Llamas-Elvira JM; Olea-Serrano N
Rev Esp Med Nucl Imagen Mol; 2012; 31(3):117-23. PubMed ID: 21676504
[TBL] [Abstract][Full Text] [Related]
7. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node pressure in breast cancer.
Nathanson SD; Mahan M
Ann Surg Oncol; 2011 Dec; 18(13):3791-6. PubMed ID: 21626079
[TBL] [Abstract][Full Text] [Related]
9. Is the "10% rule" equally valid for all subsets of sentinel-node-positive breast cancer patients?
Chung A; Yu J; Stempel M; Patil S; Cody H; Montgomery L
Ann Surg Oncol; 2008 Oct; 15(10):2728-33. PubMed ID: 18688679
[TBL] [Abstract][Full Text] [Related]
10. Role for sentinel lymph node dissection in the management of large (> or = 5 cm) invasive breast cancer.
Chung MH; Ye W; Giuliano AE
Ann Surg Oncol; 2001 Oct; 8(9):688-92. PubMed ID: 11597008
[TBL] [Abstract][Full Text] [Related]
11. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
[TBL] [Abstract][Full Text] [Related]
12. The superparamagnetic iron oxide is equivalent to the Tc99 radiotracer method for identifying the sentinel lymph node in breast cancer.
Rubio IT; Diaz-Botero S; Esgueva A; Rodriguez R; Cortadellas T; Cordoba O; Espinosa-Bravo M
Eur J Surg Oncol; 2015 Jan; 41(1):46-51. PubMed ID: 25466980
[TBL] [Abstract][Full Text] [Related]
13. Intraoperative subareolar injection of 99mTc-labeled sulfur colloid results in consistent sentinel lymph node identification.
Zogakis TG; Wetherille RE; Christensen RD; Ose KJ; Friedman JD; Colbert M; Svendsen CA; Sanan OK; Tuttle TM
Ann Surg Oncol; 2005 Feb; 12(2):167-72. PubMed ID: 15827798
[TBL] [Abstract][Full Text] [Related]
14. [Incidence of axillary recurrence after a negative sentinel lymph node result in early stages of breast cancer: a 5-year follow-up].
Ruano Pérez R; Ramos Boyero M; García-Talavera Fernández JR; Ramos Grande T; González-Orús JM; Gómez-Caminero López F; García Macias MC; Martín de Arriba A
Rev Esp Med Nucl Imagen Mol; 2012; 31(4):173-7. PubMed ID: 23067685
[TBL] [Abstract][Full Text] [Related]
15. Axillary reverse mapping with indocyanine green or isosulfan blue demonstrate similar crossover rates to radiotracer identified sentinel nodes.
Foster D; Choy N; Porter C; Ahmed S; Wapnir I
J Surg Oncol; 2018 Mar; 117(3):336-340. PubMed ID: 29228459
[TBL] [Abstract][Full Text] [Related]
16. Triple assessment of sentinel lymph node metastasis in early breast cancer using preoperative CTLG, intraoperative fluorescence navigation and OSNA.
Mokhtar M; Tadokoro Y; Nakagawa M; Morimoto M; Takechi H; Kondo K; Tangoku A
Breast Cancer; 2016 Mar; 23(2):202-10. PubMed ID: 25069434
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.
Choi SH; Barsky SH; Chang HR
Breast J; 2003; 9(3):153-62. PubMed ID: 12752622
[TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node biopsy in patients with previous ipsilateral complete axillary lymph node dissection.
Kaur P; Kiluk JV; Meade T; Ramos D; Koeppel W; Jara J; King J; Cox CE
Ann Surg Oncol; 2011 Mar; 18(3):727-32. PubMed ID: 20593244
[TBL] [Abstract][Full Text] [Related]
19. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer.
Cox CE; Pendas S; Cox JM; Joseph E; Shons AR; Yeatman T; Ku NN; Lyman GH; Berman C; Haddad F; Reintgen DS
Ann Surg; 1998 May; 227(5):645-51; discussion 651-3. PubMed ID: 9605656
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of sentinel lymph node micrometastases in patients with invasive breast carcinoma.
Cipolla C; Graceffa G; La Mendola R; Fricano S; Fricano M; Vieni S
Ann Ital Chir; 2015; 86():497-502. PubMed ID: 26898168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
